Spectra7 Announces Omar Javaid As The New CEO
| |
Three Months Ended September 30, |
Nine Months Ended September 30, |
|||||||||||
| |
(In thousands) |
|
(In thousands) |
||||||||||
| |
2024 |
|
2023 |
|
Change |
|
|
2024 |
|
2023 |
|
Change |
|
| |
$ |
|
$ |
|
$ |
% |
|
$ |
|
$ |
|
$ |
% |
| Revenue |
152 |
|
3,154 |
|
(3,002) |
(95 |
|
1,830 |
|
9,555 |
|
(7,725) |
(81 |
| Cost of sales |
169 |
|
1,568 |
|
(1,399) |
(89 |
|
966 |
|
3,950 |
|
(2,984) |
(76 |
| Gross profit |
(17) |
|
1,586 |
|
(1,603) |
(101 |
|
864 |
|
5,605 |
|
(4,741) |
(85 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gross margin % |
(11 |
|
50 |
|
(61 |
|
|
47 |
|
59 |
|
(12 |
|
3
Non-IFRS operating expenses is a non-GAAP measure which includes research and development, sales and marketing, general and administrative expenses and depreciation and amortization for capital equipment and right-of-use assets and excludes share-based compensation expense, non-recurring termination costs, interest and related financing costs, change in fair value of warrant liabilities, foreign exchange gain/loss and gain/loss from property and equipment disposal. Refer to "Non-GAAP Measures" in the MD&A and the table below for reconciliation to measures reported in the Company's financial statements.
| |
|
in thousands |
|||||||||
| |
|
2022 |
|
2023 |
|
2024 |
|||||
| |
|
Dec 31 |
|
|
Jun 30 |
Sep 30 |
Dec 31 |
|
Mar 31 |
Jun 30 |
Sep 30 |
| |
|
$ |
|
$ |
$ |
$ |
$ |
|
$ |
$ |
$ |
| |
|
|
|
|
|
|
|
|
|
|
|
| Total expenses - IFRS |
|
3,210 |
|
3,053 |
3,330 |
3,086 |
4,479 |
|
2,575 |
9,866 |
2,461 |
| Share‐based compensation |
|
469 |
|
541 |
486 |
288 |
334 |
|
182 |
270 |
143 |
| Interest on lease obligation of right-of-use assets |
|
3 |
|
1 |
4 |
4 |
3 |
|
1 |
3 |
4 |
| Accretion expense |
|
425 |
|
370 |
389 |
411 |
493 |
|
538 |
142 |
- |
| Other income |
|
- |
|
- |
(12) |
(30) |
(9) |
|
- |
10 |
- |
| Foreign exchange gain |
|
354 |
|
(72) |
57 |
(110) |
143 |
|
(211) |
27 |
(1) |
| Extingushment of convertible debt |
|
- |
|
- |
- |
- |
- |
|
- |
6,922 |
- |
| Non-IFRS operating expenses |
|
1,959 |
|
2,212 |
2,407 |
2,523 |
3,515 |
|
2,065 |
2,491 |
2,315 |
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
in thousands |
|||||||||
| |
|
2022 |
|
2023 |
|
2024 |
|||||
| |
|
Dec 31 |
|
|
Jun 30 |
Sep 30 |
Dec 31 |
|
Mar 31 |
Jun 30 |
Sep 30 |
| |
|
$ |
|
$ |
$ |
$ |
$ |
|
$ |
$ |
$ |
| |
|
|
|
|
|
|
|
|
|
|
|
| Research and development, net of investment tax |
|
928 |
|
995 |
1,195 |
1,409 |
1,154 |
|
1,040 |
1,123 |
1,033 |
| Sales and marketing |
|
280 |
|
269 |
252 |
271 |
325 |
|
279 |
270 |
236 |
| General and administrative |
|
684 |
|
881 |
891 |
762 |
1,947 |
|
657 |
1,014 |
963 |
| Depreciation of right-of-use assets |
|
60 |
|
60 |
60 |
60 |
60 |
|
60 |
57 |
56 |
| Depreciation of property and equipment |
|
8 |
|
8 |
8 |
21 |
28 |
|
28 |
28 |
27 |
| Non-IFRS operating expenses |
|
1,959 |
|
2,212 |
2,407 |
2,523 |
3,515 |
|
2,065 |
2,491 |
2,315 |
4 EBITDA or earnings before interest, tax, depreciation, and amortization is a non-GAAP measure. EBITDA excludes share-based compensation, amortization, depreciation, interest, and tax expenses. Refer to "Non-GAAP Measures" in the MD&A and the table below for reconciliation
to measures reported in the Company's
annual financial statements.
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
in thousands |
|||||||||
| |
|
2022 |
|
2023 |
|
2024 |
|||||
| |
|
Dec 31 |
|
|
Jun 30 |
Sep 30 |
Dec 31 |
|
Mar 31 |
Jun 30 |
Sep 30 |
| |
|
$ |
|
$ |
$ |
$ |
$ |
|
$ |
$ |
$ |
| |
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
(1,231) |
|
(1,090) |
(1,275) |
(1,500) |
(4,315) |
|
(2,242) |
(9,318) |
(2,477) |
| Depreciation of right-of-use assets |
|
60 |
|
60 |
60 |
60 |
60 |
|
60 |
57 |
56 |
| Depreciation of property and equipment |
|
8 |
|
8 |
8 |
21 |
28 |
|
28 |
28 |
27 |
| Depreciation expense - COGS |
|
35 |
|
35 |
30 |
31 |
31 |
|
32 |
32 |
25 |
| Amortization - intangible assets |
|
55 |
|
76 |
105 |
90 |
179 |
|
167 |
167 |
167 |
| Share-based compensation |
|
469 |
|
541 |
486 |
288 |
334 |
|
182 |
270 |
143 |
| Interest on lease obligation of right-of-use assets |
|
3 |
|
1 |
4 |
4 |
3 |
|
1 |
3 |
4 |
| Accretion expense |
|
425 |
|
370 |
389 |
411 |
493 |
|
538 |
142 |
- |
| Other income |
|
- |
|
- |
(12) |
(30) |
(9) |
|
- |
10 |
- |
| Foreign Tax |
|
(216) |
|
- |
- |
- |
(119) |
|
- |
- |
- |
| Foreign exchange gain |
|
354 |
|
(72) |
57 |
(110) |
143 |
|
(211) |
27 |
(1) |
| Extingushment of convertible debt |
|
- |
|
- |
- |
- |
- |
|
- |
6,922 |
- |
| EBITDA |
|
(38) |
|
(70) |
(148) |
(734) |
(3,172) |
|
(1,445) |
(1,659) |
(2,056) |
ABOUT SPECTRA7 MICROSYSTEMS INC.
Spectra7 Microsystems Inc. is a leader in high-performance analog semiconductors for powering the AI revolution in broadband connectivity markets, hyperscale data centers, and Spatial Computing.
Spectra7 is based in San Jose, California with a design center in Cork, Ireland and a technical support location in Dongguan, China. For more information,
please visit
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
CAUTIONARY NOTES
Certain statements contained in this press release constitute "forward-looking statements". All statements other than statements of historical fact contained in this press release, including, without limitation, the Company's timeline for its 224Gbps product, the new CEO's ability to transform the Company's strategy, secure key customer wins, and accelerate growth, the Company's strategy, plans, objectives, goals and targets, and any statements preceded by, followed by or that include the words "believe", "expect", "aim", "intend", "plan", "continue", "will", "may", "would", "anticipate", "estimate", "forecast", "predict", "project", "seek", "should" or similar expressions or the negative thereof, are forward-looking statements. These statements are not historical facts but instead represent only the Company's expectations, estimates and projections regarding future events. These statements are not guarantees of future performance and involve assumptions, risks and uncertainties that are difficult to predict. Therefore, actual results may differ materially from what is expressed, implied or forecasted in such forward-looking statements. Additional factors that could cause actual results, performance or achievements to differ materially include, but are not limited to, the risk factors discussed in the Company's management's discussion and analysis for the year ended December 31, 2023.. Management provides forward-looking statements because it believes they provide useful information to investors when considering their investment objectives and cautions investors not to place undue reliance on forward-looking information. Consequently, all of the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors contained herein, and there can be no assurance that the actual results or developments will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, the Company. These forward-looking statements are made as of the date of this press release and the Company assumes no obligation to update or revise them to reflect subsequent information, events or circumstances or otherwise, except as required by law.
For more information, please contact:
Matt Kreps, Managing Director
Darrow Associates Investor Relations
[email protected]
214-597-8200
Spectra7 Microsystems Inc.
Dave Mier
Interim Chief Financial Officer
925-858-7011
[email protected]
SOURCE Spectra7 Microsystems Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment